Unveiling the Role of Genes in Biology
Transcription is a central process in gene expression and regulation. Elucidation of the molecular mechanisms governing transcription, such as RNA synthesis and gene regulation, is fundamental to modern biology. Emerging techniques, such as deep sequencing, chemical biology, and proteomic studies, have brought new insights into transcription regulatory mechanisms.
The IAS Focused Program on Mechanisms of Gene Transcription and its Regulations built on the remarkable success of a similar event in 2016. The Program attracted members of the US National Academy of Sciences, Howard Hughes Medical Institute, and Fellows of the Royal Society in the UK to join in a focused conversation on the latest developments in research and technology. There were encouraging signs that Asia is developing into a new research leader in the field of gene transcription and regulation. The overwhelmingly positive feedback supported the planning of more events of this kind in the future.
IAS Focused Program on Mechanisms of Gene Transcription and its Regulations (March 19 - 23, 2018)
Combatting Alzheimer’s Disease
Croucher Advanced Study Institute on Setting the Future Directions of Alzheimer’s Disease Research (March 26 - 28, 2018)
Alzheimer’s disease is an increasingly serious health issue for the aging global population. Attempts to treat this condition have witnessed repeated failures at the advanced stage of clinical trials. The last new drug approved by the US Food and Drug Administration (FDA) was brought to the market in 2003. The slow progress in finding a cure for the disease calls for a structural review of the research community and the market.
Co-sponsored by the Croucher Foundation, the IAS, and the Alzheimer’s Association, the Croucher Advanced Study Institute on Setting the Future Directions of Alzheimer’s Disease Research was a three-day meeting to review the current status of the field. The meeting was chaired by a blue-ribbon panel of experts, all of whom are authorities in the field but had not worked directly on Alzheimer’s disease. They addressed the overall strategy in combatting the disease and the failure of the research community to evolve structurally.